A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris

PHASE1CompletedINTERVENTIONAL

Enrollment

1,000

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

November 30, 2015

Conditions

Acne Vulgaris

Interventions

DRUG

Clindamycin and Benzoyl Peroxide Gel 1%5%

Clindamycin and Benzoyl Peroxide Gel 1%5% (Taro Pharmaceuticals Inc.)

DRUG

BenzaClin® Topical Gel

BenzaClin® (clindamycin 1%/benzoyl peroxide 5%) Topical Gel (Sanofi Aventis, U.S.)

DRUG

Placebo

Placebo (vehicle of the test product) (Taro Pharmaceuticals Inc.)

All Listed Sponsors

lead

Sun Pharmaceutical Industries, Inc.

INDUSTRY

NCT02595034 - A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter